We operate a free-to-view policy, asking only that you register in order to read all of our content. Please login or register to view the rest of this article.
ARTICLE · 14 OCTOBER 2016
IPO's Patent To Gilead's Sofobuvir (Sovaldi) Challenged At Delhi High Court
H K Acharya & Co
A Writ Petition has been filed before the Delhi High Court, challenging the grant of patent for Gilead's megahit anti Hepatitis-C virus drug, sofobuvir which is known commercially everywhere as "Sovaldi".
IndiaIntellectual Property







